Viavi Solutions Inc has a consensus price target of $11.78 based on the ratings of 10 analysts. The high is $17 issued by Northland Capital Markets on March 6, 2024. The low is $8.25 issued by Rosenblatt on June 26, 2024. The 3 most-recent analyst ratings were released by Rosenblatt on June 26, 2024, May 3, 2024, and April 3, 2024, respectively. With an average price target of $10.42 between Rosenblatt, there's an implied 37.97% upside for Viavi Solutions Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/26/2024 | Buy Now | 9.27% | Rosenblatt | Mike Genovese | $10 → $8.25 | Downgrade | Buy → Neutral | Get Alert |
05/03/2024 | Buy Now | 32.45% | Rosenblatt | Mike Genovese | $13 → $10 | Maintains | Buy | Get Alert |
05/03/2024 | Buy Now | — | Needham | Ryan Koontz | — | Reiterates | → Hold | Get Alert |
04/03/2024 | Buy Now | 72.19% | Rosenblatt | Mike Genovese | $15 → $13 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | 72.19% | Stifel | Ruben Roy | $13 → $13 | Maintains | Buy | Get Alert |
04/01/2024 | Buy Now | — | Needham | Alex Henderson | — | Reiterates | → Hold | Get Alert |
03/07/2024 | Buy Now | 85.43% | Susquehanna | Mehdi Hosseini | $12 → $14 | Maintains | Positive | Get Alert |
03/06/2024 | Buy Now | 125.17% | Northland Capital Markets | Tim Savageaux | $12 → $17 | Maintains | Outperform | Get Alert |
03/06/2024 | Buy Now | 45.7% | Morgan Stanley | Meta Marshall | $9 → $11 | Maintains | Equal-Weight | Get Alert |
03/06/2024 | Buy Now | 98.68% | Rosenblatt | Mike Genovese | $13 → $15 | Maintains | Buy | Get Alert |
02/12/2024 | Buy Now | 72.19% | Stifel | Ruben Roy | $10 → $13 | Upgrade | Hold → Buy | Get Alert |
12/13/2023 | Buy Now | 58.94% | Rosenblatt | Mike Genovese | $10 → $12 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | 32.45% | Rosenblatt | Mike Genovese | $14 → $10 | Maintains | Buy | Get Alert |
11/03/2023 | Buy Now | 19.21% | Morgan Stanley | Connor Lynagh | $10 → $9 | Maintains | Equal-Weight | Get Alert |
08/31/2023 | Buy Now | 85.43% | Rosenblatt | Mike Genovese | → $14 | Reiterates | Buy → Buy | Get Alert |
08/11/2023 | Buy Now | 85.43% | Rosenblatt | Mike Genovese | $13 → $14 | Maintains | Buy | Get Alert |
06/09/2023 | Buy Now | 72.19% | Rosenblatt | Mike Genovese | → $13 | Reiterates | Buy → Buy | Get Alert |
05/03/2023 | Buy Now | 32.45% | Morgan Stanley | Connor Lynagh | $10.5 → $10 | Maintains | Equal-Weight | Get Alert |
05/03/2023 | Buy Now | 58.94% | Susquehanna | Mehdi Hosseini | $14 → $12 | Maintains | Positive | Get Alert |
05/03/2023 | Buy Now | 72.19% | Rosenblatt | Mike Genovese | → $13 | Reiterates | → Buy | Get Alert |
04/18/2023 | Buy Now | 45.7% | B. Riley Securities | Dave Kang | $13.5 → $11 | Maintains | Neutral | Get Alert |
04/18/2023 | Buy Now | 85.43% | Susquehanna | Mehdi Hosseini | $16 → $14 | Maintains | Positive | Get Alert |
04/18/2023 | Buy Now | 39.07% | Morgan Stanley | Connor Lynagh | $13 → $10.5 | Maintains | Equal-Weight | Get Alert |
04/18/2023 | Buy Now | 72.19% | Rosenblatt | Mike Genovese | $16 → $13 | Maintains | Buy | Get Alert |
02/03/2023 | Buy Now | 78.81% | B. Riley Securities | Dave Kang | $14.5 → $13.5 | Maintains | Neutral | Get Alert |
12/20/2022 | Buy Now | 45.7% | JP Morgan | Samik Chatterjee | $13 → $11 | Maintains | Neutral | Get Alert |
12/02/2022 | Buy Now | 58.94% | Stifel | Ruben Roy | → $12 | Initiates | → Hold | Get Alert |
11/07/2022 | Buy Now | 72.19% | Morgan Stanley | Meta Marshall | $16 → $13 | Maintains | Equal-Weight | Get Alert |
11/04/2022 | Buy Now | 92.05% | B. Riley Securities | Dave Kang | $21 → $14.5 | Downgrade | Buy → Neutral | Get Alert |
10/11/2022 | Buy Now | 111.92% | Morgan Stanley | Meta Marshall | $17 → $16 | Maintains | Equal-Weight | Get Alert |
10/06/2022 | Buy Now | 138.41% | Rosenblatt | Mike Genovese | → $18 | Initiates | → Buy | Get Alert |
09/14/2022 | Buy Now | 125.17% | Morgan Stanley | Meta Marshall | $16 → $17 | Maintains | Equal-Weight | Get Alert |
08/12/2022 | Buy Now | 138.41% | Susquehanna | Mehdi Hosseini | $20 → $18 | Maintains | Positive | Get Alert |
07/19/2022 | Buy Now | — | Needham | Alex Henderson | — | Downgrade | Buy → Hold | Get Alert |
07/14/2022 | Buy Now | 98.68% | JP Morgan | Samik Chatterjee | $18 → $15 | Maintains | Neutral | Get Alert |
05/04/2022 | Buy Now | 111.92% | Morgan Stanley | Meta Marshall | $17 → $16 | Maintains | Equal-Weight | Get Alert |
08/13/2021 | Buy Now | 151.66% | Morgan Stanley | Meta Marshall | — | Maintains | Equal-Weight | Get Alert |
The latest price target for Viavi Solutions (NASDAQ:VIAV) was reported by Rosenblatt on June 26, 2024. The analyst firm set a price target for $8.25 expecting VIAV to rise to within 12 months (a possible 9.27% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Viavi Solutions (NASDAQ:VIAV) was provided by Rosenblatt, and Viavi Solutions downgraded their neutral rating.
The last upgrade for Viavi Solutions Inc happened on February 12, 2024 when Stifel raised their price target to $13. Stifel previously had a hold for Viavi Solutions Inc.
The last downgrade for Viavi Solutions Inc happened on June 26, 2024 when Rosenblatt changed their price target from $10 to $8.25 for Viavi Solutions Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viavi Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viavi Solutions was filed on June 26, 2024 so you should expect the next rating to be made available sometime around June 26, 2025.
While ratings are subjective and will change, the latest Viavi Solutions (VIAV) rating was a downgraded with a price target of $10.00 to $8.25. The current price Viavi Solutions (VIAV) is trading at is $7.55, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.